Cut Timelines and Costs in Late-Phase Oncology: Why Asia Should Be Your Next Trial Destination
Globally, cancer diagnoses are projected to reach 35.3 million new cases per year with death rates rising to 18.5 million by 2050.²
Search results
We found 166 results for: “phase ii”
Avance Clinical Partners with China Medical University Hospital in Taiwan to Strengthen Early-to-Late Phase Clinical Trial Pathway
CMUH is renowned for its excellence in conducting clinical trials, and Avance Clinical specializes in early-phase clinical researchers.
Avance Clinical Leads as the CRO of Choice for Early Phase Clinical Trials in Australia – Announced at Biotech Showcase 2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for early phase clinical trials in Australia.
Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)
Discover an informative webinar that delves into the strategic benefits of conducting early-phase oncology clinical development across Australia and the USA.
Clinical Leader Solutions Expo: Early-Phase Oncology Trials (CRO)
As small and emerging biopharma companies now lead 70% of trial starts, navigating the complexities of early-phase oncology trials requires the support of expert CRO partners.
Strategic Advantages of Early-Phase Oncology Clinical Development Across Australia and the USA
Oncology has been and continues to be the leading priority in global drug development. 44% of all Phase I-III trials, current and planned, are tackling oncology. But as the push to combat cancer evolves, so too has the drug development arena. In the last decade, ...
Phase II / Late Phase
As your drug development journey progresses, the Avance Clinical team can transition your clinical research from early to late phase multi-regional studies with the assurance that the global team brings the same expertise and professionalism you have come to expect. All the while saving time ...
Phase I / Early Phase
The biotech drug development journey with Avance Clinical starts with robust early phase clinical foundations.
Oragenics Partners with Avance Clinical for Phase II Concussion Trial in Australia
Oragenics, Inc. (NYSE American: OGEN), a pioneer in developing innovative intranasal pharmaceuticals for neurological disorders, today announced a partnership with Avance Clinical, a leading Contract Research Organization (CRO), to conduct a Phase II clinical trial in Australia
SAB Biotherapeutics Announces Commencement of the HUMAN Phase 1 Clinical Trial with SAB-142, a Potential DiseaseModifying Treatment for Type 1 Diabetes
SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is developing fully-human anti-thymocyte immunoglobulin (hIgG) for disease-modification of Type 1 Diabetes (T1D) through delaying the onset and/or progression of the disease, today announced that the first participants of a ...